Affiliation:
1. From the Department of Obstetrics and Gynecology, Brown Medical School, and the Women & Infants Hospital of Rhode Island, Providence, Rhode Island
Abstract
OBJECTIVE—To provide a review of the background literature regarding the pharmacological management of gestational diabetes.
RESEARCH DESIGN AND METHODS—This is a literature review.
RESULTS—Information is available regarding the use of some, but not all, oral antidiabetes agents in pregnancy.
CONCLUSIONS—Available evidence supports the use of glyburide during pregnancy. Evidence is inadequate to support or refute the use of metformin, an agent that has been shown to cross the placenta and thus could be helpful or harmful to the developing fetus.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference13 articles.
1. Miller DI, Wishinsky H, Thompson G: Transfer of tolbutamide across the placenta. Diabetes 11 (Suppl.):93–97, 1962
2. Elliott BD, Langer O, Schenker S, Johnson RF: Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 165:807–812, 1991
3. Elliott BD, Langer O, Schenker S, Johnson RF, Prihoda T: Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 171:653–660, 1994
4. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O: A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134–1138, 2000
5. Physicians’ Desk Reference. 59th ed. Montvale, NJ, Thomson PDR, 2005, p. 2375–2377
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献